25 Best US Cities for People With Allergies

In This Article:

In this article, we will take a look at the 25 best US cities for people with allergies. If you want to see more cities in this selection, go to the 5 Best US Cities for People With Allergies.

According to Allied Market Research, the market for allergy treatments was valued at $24.6 billion in 2017. As per projections, this figure is set to increase to $40.3 billion by 2025, reflecting a compound annual growth rate (CAGR) of 6.3% from 2018 to 2025. The rise in the prevalence of allergic diseases, an increasing preference for over-the-counter medications for allergy treatment, and a growing trend of self-medication among consumers are among the main driving forces behind the growth of the global market for allergy treatment. Furthermore, the effects of climate change have resulted in prolonged and warmer growing seasons, consequently leading to increased pollen counts from trees, grass, and weeds. In certain regions of the United States, pollen is now present throughout the year. Allergic conditions rank among the prevalent medical conditions in the US, impacting a significant portion of the population. Each year, over 100 million Americans experience various types of allergies.

According to the Asthma and Allergy Foundation of America (AAFA), seasonal allergic rhinitis, commonly known as "hay fever," is one of the most widespread allergic conditions, with approximately 26% of adults and 19% of children having received a diagnosis for this condition in 2021. As per Future Market Insights, in terms of geographic distribution, North America accounted for approximately one-third of the global seasonal allergy market value in 2022, primarily due to the growing incidence of seasonal allergies within the region. While in terms of the distribution of drugs, hospital pharmacies held a significant share of approximately 35.9% due to their access to a wide range of specialty drugs that may not be readily available at retail pharmacies. New allergy treatment options, including anti-IL-5 therapy and anti-IgE therapy, and the development of minimally invasive allergy testing approaches such as skin patch testing and blood tests are some of the key trends expected to drive the growth of the allergy market.

Different strategies are being adopted by manufacturers in the allergy care industry to capture a greater market share, such as expanding manufacturing facilities to increase production capacities, creating personalized treatments, and forming partnerships with healthcare professionals to conduct clinical research and development. Manufacturers are focusing on strengthening their regional presence by offering specialized products such as nasal sprays and eye drops to treat allergies. According to FactMr, this targeted approach is anticipated to significantly boost their revenue, potentially resulting in a 1.5X increase within the next five years. The international allergy care market is characterized by high fragmentation and intense competition, primarily due to the presence of numerous domestic and regional players. Some notable players in the market include Johnson & Johnson (NYSE:JNJ), Pfizer Inc. (NYSE:PFE), GSK plc (LON:GSK), Novartis AG (NYSE:NVS), and AstraZeneca PLC (NASDAQ:AZN). Furthermore, startups such as Third Harmonic Bio Inc (NASDAQ:THRD), Connect Biopharma Holdings Ltd (NASDAQ:CNTB), and GentiBio are also actively investing in the research and development of drugs to treat allergic diseases.